STAT Plus: The health tech tracker for the fourth quarter: 14 pivotal industry events to watch
Welcome to STAT’s Health Tech Tracker, a ledger of all the major data readouts, product…
Category: Biotech
New research shows older adults are still often excluded from clinical trials
For years, researchers have called out a glaring gap in many clinical trials: Despite having…
Trump’s debate highlights his hunger for a rushed, election-eve vaccine approval
WASHINGTON — President Trump spoke on Tuesday as if his campaign depends on a Covid-19…
Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before
WASHINGTON — Not only has he lowered drug prices, President Trump claimed in the first…
Regeneron’s Covid-19 antibody may help non-hospitalized patients recover faster, early data show
New data from the biotechnology firm Regeneron seem likely to add to the excitement about…
STAT Plus: For two decades, the FDA approval process for opioids had numerous shortcomings, study finds
Over more than two decades, the Food and Drug Administration approved opioid painkillers based on…
STAT Plus: STAT+ Conversations: How Covid-19 will change drug development
Editor’s note: A live stream of the conversation will be embedded below at 1 p.m….
STAT Plus: Catalyst loses lawsuit accusing the FDA of unfairly approving a rival rare disease drug
In a blow to Catalyst Pharmaceuticals (CPRX), a federal judge dismissed its lawsuit accusing the…
STAT Plus: Pharmalittle: Biden getting more pharma donations than Trump; FDA safety plan not ‘well suited’ for opioids
Good morning, everyone, and nice to be back after an extended weekend break. Nonetheless, time…
STAT Plus: Drug industry CEOs will testify this week about some of pharma’s most controversial medicines
The House Oversight Committee will hold two days of hearings this week with six drug…
Opinion: Increase transparency at the FDA: We need sunlight to fight the pandemic
The Food and Drug Administration has issued a number of contentious decisions during the Covid-19…
As insurers move this week to stop waiving telehealth copays, patients may have to pay more for virtual care
Starting Oct. 1, several private health insurers will no longer fully pay for virtual visits…
.jpg)
STAT Plus: An FDA safety program is failing to stem the opioid crisis — and manufacturers are mostly to blame
A mandated safety program regulators rely on to minimize opioid abuse and misuse is not…
STAT Plus: With a new law, California becomes the first state to pursue its own line of generics
In a groundbreaking move, California adopted a law Monday to allow the state to develop…
STAT Plus: Pharmalittle: Operation Warp Speed is more Army than science; J&J’s Covid-19 vaccine moves forward
Good morning, one and all. Damian Garde here, filling in for Ed Silverman at the…
Opinion: Global investors must support pharma solidarity and collaboration in the response to Covid-19
The prospect of having the first supplies of at least a few effective Covid-19 medicines…
Opinion: Pregnant and lactating women should not be excluded from Covid-19 drug, vaccine trials
Citizens of the world are holding their collective breath while awaiting vaccines and therapies to…
STAT Plus: The 8 most important leaders of Operation Warp Speed
Below are the eight most important people leading Operation Warp Speed. It is based on…
A layperson’s guide to how — and when — a Covid-19 vaccine could be authorized
In a U.S. pandemic response dominated by missteps, the effort to develop vaccines to prevent…
New document reveals scope and structure of Operation Warp Speed and underscores vast military involvement
WASHINGTON — When President Trump unveiled Operation Warp Speed in May, he declared that it…
Republicans blasted Obama’s use of an obscure Medicare law. Now Trump’s using it on $200 drug coupons — and the GOP is silent
WASHINGTON — The last time a president used an obscure law to spend billions of…
.jpg)
STAT Plus: ‘The largest application we can imagine’: Illumina and Grail CEOs defend their deal to investors
Shares of Illumina, the leader in DNA sequencing, have dropped 13% since news leaked last…
STAT Plus: Pharmalittle: In political ploy, Trump promises drug coupons to seniors; N.Y. plans its own Covid-19 vaccine reviews
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Personalized medicine is the future of health care. Two Trump administration proposals could stymie it
“It is more important to know what kind of patient the disease has than to…
Opinion: Kids’ heart rates are rising as the pandemic drags on
In mid-March, schools across the country shut down. My 7-year-old son took it well; life…
STAT Plus: Medical AI systems are disproportionately built with data from just three states, new research finds
Late last year, Stanford University researcher Amit Kaushal and a collaborator noticed something striking while…
Pharmacies are bracing for a surge in demand for flu shots amid the Covid-19 pandemic
With flu season fast approaching, and the Covid-19 pandemic raging on, hospitals and pharmacies across…
Among people of color asked to join Covid-19 vaccine trials, worries about inequities run deep
While presenting the Covid-19 vaccine study she’s running, Susan Little was asked for a promise…
Trump promises seniors $200 prescription drug gift certificates, but questions abound
WASHINGTON — President Trump on Thursday pledged to send $200 prescription drug coupons to 33…
Listen: A road map for Covid-19, the gold rush in health tech, & D.C.’s pandemic unrest
Is superspreading an Olympic event? Will Covid-19 forever change health tech? And what are the…
Brainiacs, not birdbrains: Crows possess higher intelligence long thought a primarily human attribute
Whether crows, ravens, and other “corvids” are making multipart tools like hooked sticks to reach…
Opinion: We can’t tackle the pandemic without figuring out which Covid-19 vaccines work the best
We may have a vaccine for Covid-19 by late this fall. By winter, we could…
STAT Plus: Not by the numbers: Former Aceto controller is charged with insider trading
File this under ‘What was he thinking?’ After spending nearly 17 years as controller at…
STAT Plus: A sadly familiar disappointment in Alzheimer’s research
After years of failed attempts to treat Alzheimer’s disease by targeting a toxic brain plaque…
STAT Plus: Pharmalittle: Trump may not approve FDA emergency use guidelines; U.K. starts world’s first Covid-19 challenge trial
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Opinion: Medicine for the Greater Good: one hospital’s way of supporting its nearby communities of color
The violent police attacks on Jacob Blake, George Floyd, and far too many others, along…
Opinion: The FDA approved the abortion pill 20 years ago. It’s time to make it available via telehealth
Twenty years ago this month, the Food and Drug Administration approved a medication destined to…
As hospitals look to prevent infections, a chorus of researchers make a case for copper surfaces
Keeping patients from getting sick during an inpatient stay has long been a problem for…
Here come the tortoises: In the race for a Covid-19 vaccine, slow starters could still win out
The race is not always to the swift, as the cocky hare learned in Aesop’s…
STAT Plus: Gilead to pay $97 million for allegedly using a charity to pay kickbacks to Medicare patients
Gilead Sciences (GILD) agreed to pay nearly $97 million to resolve allegations that donations it…
New research finds unapproved drugs in brain-boosting supplements
The supplement aisle is rife with “nootropics,” “smart drugs” and “cognitive enhancers” that claim to…
STAT Plus: HHS criticizes Lilly for seeking to curtail discounts for safety-net hospitals
In a stern rebuke, the Department of Health and Human Services has taken Eli Lilly…
STAT Virtual Event: The ESMO Recap, Live!
Editor’s note: A live stream of the event will be embedded above at 1:30 p.m….
STAT Plus: Public funding underwrote much of the development of J&J’s drug for TB, analysis finds
Amid ongoing debate over taxpayer dollars used to generate medicines, a new analysis contends that…
STAT Plus: Teladoc’s tussle with Amwell raises questions about defining property rights in digital health
The field of health tech is facing a big question: Can it establish strong patent…
STAT Plus: Pharmalittle: FDA to set new standard for Covid-19 vaccine; J&J starts a one-shot vaccine trial
Hello, everyone, and welcome to the middle of the week. Already, you say? Well, the…
Opinion: America’s mental health care system fell short for my brother. Access to that care should be a legal right for all
The year 2020 has put an exclamation point on the need for robust mental health…
STAT Plus: Q&A: Vivek Murthy, a top Biden adviser, on Covid-19 vaccines, the drug industry, and the future of public health
WASHINGTON — After a years-long hiatus, Vivek Murthy is back in the political spotlight. As…
Opinion: Fast, low-cost testing is essential for averting a second wave of Covid-19
Since the first Covid-19 cases emerged in the U.S. in early 2020, attitudes toward coronavirus…
When AI is the opposite of sinister: An MIT researcher is held up as model of how algorithms can benefit humanity
In June, when MIT artificial intelligence researcher Regina Barzilay went to Massachusetts General Hospital for…